At a Glance
| Oxytocin | Substance P | |
|---|---|---|
| Class | Neuropeptide | Neuropeptide, Pain mediator, Stress mediator |
| Routes | IntranasalIntravenousSublingual | |
| Effects | 7 documented |
Oxytocin, a Neuropeptide, and Substance P, a Neuropeptide, Pain mediator, Stress mediator, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Oxytocin is classified as a Neuropeptide while Substance P is a Neuropeptide, Pain mediator, Stress mediator, meaning they approach altered states through different pharmacological mechanisms. They share 0 documented effects in common, with 7 effects unique to Oxytocin and 7 unique to Substance P. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Oxytocin | Substance P | |
|---|---|---|
| Class | Neuropeptide | Neuropeptide, Pain mediator, Stress mediator |
| Routes | IntranasalIntravenousSublingual | |
| Effects | 7 documented |
| 7 documented |
| Level | Dose |
|---|---|
| Threshold | 5 IU |
| Light | 10–20 IU |
| Common | 20–40 IU |
| Strong | 40–60 IU |
| Heavy | 80 IU |
| Level | Dose |
|---|---|
| Threshold | 0.5 mU/min |
| Light | 0.5–2 mU/min |
| Common | 2–10 mU/min |
| Strong | 10–20 mU/min |
| Heavy | 40 mU/min |
| Level | Dose |
|---|---|
| Threshold | 10 IU |
| Light | 20–40 IU |
| Common | 40–80 IU |
| Strong | 80–120 IU |
| Heavy | 160 IU |
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.